These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28512229)

  • 21. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry.
    Bose M; Kamra M; Mullick R; Bhattacharya S; Das S; Karande AA
    Sci Rep; 2017 Jun; 7(1):3965. PubMed ID: 28638096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
    Zhu YZ; Qian XJ; Zhao P; Qi ZT
    World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus].
    Suda G; Yamasaki K; Sakamoto N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928
    [No Abstract]   [Full Text] [Related]  

  • 25. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
    Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
    Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Open Sesame: regulation of hepatitis C virus entry into hepatocytes].
    Turek M; Lupberger J; Baumert TF; Zeisel MB
    Med Sci (Paris); 2011 Nov; 27(11):929-31. PubMed ID: 22130016
    [No Abstract]   [Full Text] [Related]  

  • 27. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.
    Qian XJ; Zhang XL; Zhao P; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Zhu YZ; Qi ZT
    Sci Rep; 2016 Jun; 6():27268. PubMed ID: 27252043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Required concentration index quantifies effective drug combinations against hepatitis C virus infection.
    Kakizoe Y; Koizumi Y; Ikoma Y; Ohashi H; Wakita T; Iwami S; Watashi K
    Theor Biol Med Model; 2021 Jan; 18(1):4. PubMed ID: 33422060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research on hepatitis C virus entry inhibitor].
    Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
    Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entry inhibitors and future treatment of hepatitis C.
    Fofana I; Jilg N; Chung RT; Baumert TF
    Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus.
    Chamoun-Emanuelli AM; Pécheur EI; Chen Z
    Antiviral Res; 2014 Sep; 109():141-8. PubMed ID: 25019406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Ohashi H; Koizumi Y; Fukano K; Wakita T; Perelson AS; Iwami S; Watashi K
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4527-E4529. PubMed ID: 28512226
    [No Abstract]   [Full Text] [Related]  

  • 34. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
    Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
    Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
    Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment choice of the antiviral agent for the hepatitis C].
    Karino Y
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():269-73. PubMed ID: 26845943
    [No Abstract]   [Full Text] [Related]  

  • 39. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
    Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
    EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New anti-HCV drug combinations: who will benefit?
    Ferenci P
    Lancet Infect Dis; 2017 Oct; 17(10):1008-1009. PubMed ID: 28818545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.